Acuitas Lighthouse
Investors
Overview
Stock Information
News & Events
SEC Filings
Investor FAQ
Corporate Governance
Financial Information
Shareholder Services
Contact Us
News
Press Releases
OpGen In The News
Blog
Webinars
Videos
Acuitas Lighthouse
®
Overview
AMR Prediction
Surveillance
Patients at Risk
Hospitals & Health Networks
Pharma and CROs
Acuitas Publications
Acuitas
®
Tests
Overview
AMR Gene Panel
Whole Genome Sequencing
Acuitas SDS
Acuitas Publications
AdvanDx
®
Pathogen ID
Overview
QuickFISH
®
Products
Staphylococcus QuickFISH
®
Enterococcus QuickFISH
®
Gram-Negative QuickFISH
®
Candida QuickFISH
®
PNA FISH
®
Products
S. aureus/CNS PNA FISH
®
E. faecalis/OE PNA FISH
®
Gram-Negative PNA FISH
®
Candida PNA FISH
®
Accessories
AdvanDx SDS
AdvanDx Publications
Distributors
Curetis Europe
Curetis USA
Ares Genetics
About
Overview
Antibiotic Stewardship
Management Team
Board of Directors
Clinical Advisory Board
Careers
Investors
Stock Information
News & Events
SEC Filings
Investor FAQ
Corporate Governance
Financial Information
Shareholder Services
Contact Us
News
Press Releases
OpGen In The News
Blog
Webinars
Videos
Acuitas Lighthouse Login
Blog
OpGen In The News
Antibiotic resistant co-infections: A silent killer in COVID-19 patients
May, 2020
Using Broader Diagnostics To Detect Bacterial Co-Infections And Drug Resistance In COVID-19 Patients
May, 2020
The Need for Broader Testing of COVID-19 Patients
May, 2020
OpGen, Sweden’s Karolinska Institutet to Study Bacterial Co-Infections in COVID-19 Pneumonia Patients
April, 2020
COVID-19 Patients Need to be Tested for Bacteria and Fungi, Not Just the Coronavirus
April, 2020
Technology takes the top position in outbreak management
April, 2020
Uncovering bacterial co-infections in COVID-19 patients with broader diagnostics
April, 2020
OpGen Completes Business Combination with Curetis
April, 2020
OpGen Closes On Curetis Purchase
April, 2020
Applying New Diagnostic Technologies in Long-Term Care
January, 2020
Fighting Infections with Genomic Testing: Evan Jones of OpGen Describes Exciting New Technology
January, 2020
Why cloud-based data collaboration tech could defend against superbug outbreaks
December, 2019
The Missing Link in Fighting Antibiotic Resistance
December, 2019
New Technology Can Identify Bacteria’s Genetic Make-Up, Fight Drug Resistance
October, 2019
OpGen CEO Evan Jones Appears on Digital Trends Live to Discuss Antibiotic Resistance
September, 2019
Improving infection control with new diagnostic technologies
September, 2019
A new light on antibiotic resistance
September, 2019
Gaithersburg’s OpGen to combine with German molecular diagnostic company
September, 2019
OpGen Progresses on Pipeline of Highly Multiplexed Drug-Resistant Bacteria Tests
August, 2019
The growing role of rapid diagnostics and digital health In long-term care
July, 2019
OpGen’s Acuitas
®
AMR Gene Panel shows potential for reducing total time to targeted therapy
June, 2019
On The Mend Episode 8
June, 2019
Diagnostic test allows outbreak testing to begin more quickly than current WGS
June, 2019
Immune to drugs: Antimicrobial resistance could kill 10 million a year
May, 2019
OpGen submits antibiotic resistance test to FDA
May, 2019
Resist This: New York State Department of Health, ILÚM, OpGen Partner to Fight Antimicrobial Resistance
May, 2019
Top stories in infectious disease: FDA rejects antibiotic to treat complicated UTIs, US measles cases highest since 1994
April, 2019
Stopping Infection Outbreaks in Their Tracks With Diagnostic Technology
April, 2019
Q&A: Preventing hospital outbreaks with surveillance technology
March, 2019
Boosting infection control with new diagnostics
March, 2019
OpGen’s Bet on Precision Antibiotics
February, 2019
Healthcare has a $20B “Super” Problem: Precision Medicine is Here to Cut Costs and Save Lives
January, 2019
Next-Gen Technologies Aim to Reform the Microbiology Lab, But Do They Pose Significant Threats to the Big Guys?
December, 2018
OpGen Receives Regulatory Approval to Market Pathogen Identification Products in Colombia
December, 2018
In Brief This Week: Precipio, OpGen, Genedrive, and Danaher
December, 2018
OpGen Completes Specimen Accrual and Testing in Acuitas
®
Clinical Verification Study
November, 2018
New York State Initiative Hopes to Stop the Spread of Super Bugs
October, 2018
Solving healthcare’s $20 billion superbug problem
October, 2018
DOH joins private partners to fight ‘superbugs’
October, 2018
Healthcare’s $20B “super” problem
October, 2018
OpGen Partners With NYS DOH, Merck Subsidiary for Antimicrobial Resistance Surveillance
September, 2018
OpGen signs deal with New York health department to research superbugs
September, 2018
OpGen signs deal with New York health department to research superbug
September, 2018
